Celeste Krewson, Assistant Editor

Nanette F. Santoro, MD, chair of OBGYN at the University of Colorado School of Medicine, discusses new research on fezolinetant as a nonhormone method for managing hot flashes at the 2023 Menopause Society Annual Meeting.

In a recent study, patients with early-stage cervical cancer receiving radical hysterectomy had increased survivability.

In a recent study, preexposure prophylaxis nurses effectively increased rates of preexposure prophylaxis discussions, but not prescriptions.

In a recent study, increased hair cortisol levels were effective at measuring worsened cognitive health in perimenopausal women.

In a recent study, hot flashes were indicated to be an underlying risk factor for cardiovascular disease.

In a recent study, variations in physiology during aging were found between male and female participants.

Recent data from the CDC has indicated provider recommendation increases vaccine coverage among pregnant women.

In a recent study, patients with chronic vulvar pain conditions had decreased pain-related anxiety and improved sexual functioning when experiencing vulvar pleasure.

Commons forms of osteoarthritis, as well as prevention methods, were discussed at The Menopause Society 2023 annual conference.

The most recommended and non-recommended methods of nonhormone therapy for treatment of vasomotor symptoms were discussed at The Menopause Society 2023 Annual Conference.

Advancements in technology used to measure bone health in postmenopausal women were discussed at the Menopause Society 2023 Annual Meeting.

A recent study measuring sexual functioning in women with post-traumatic stress disorder was discussed at The Menopause Society 2023 Annual Meeting.

Genevieve Neal-Perry, MD, discusses how fezolinetant is effective for treating vasomotor symptoms.

A nationwide recall has been issued for ibrexafungerp products after a potential cross contamination with a non-antibacterial ß-lactam drug substance was discovered.

In a recent study highlighted at the Menopause Society 2023 Annual Meeting, a correlation was found between the number of hot flashes experienced and the risk of Alzheimer’s disease among perimenopausal and postmenopausal women.

A correlation between brown adipose tissue activity and hot flashes was discussed at the Menopause Society 2023 Annual Conference.

In a recent study, increased use of cannabis to manage menopause symptoms was observed among midlife women.

In a recent study highlighted at The Menopause Society 2023 Annual Meeting, White women with a psychiatric condition were 40% more likely to receive a hormone therapy prescription than Black women.

At The Menopause Society 2023 Annual Meeting, tips on reducing weight during menopause will be discussed.

In a recent study, the risk of cerebral palsy was slightly increased among children conceived in the winter and spring compared to summer.

In a recent study, transgender women had reduced sperm quality compared to cisgender men, and transgender men used contraception at similar rates to cisgender women.

In a recent study, ages at menarche and menopause, as well as pregnancy history, impacted the risk of endometrial cancer.

In a recent study, Black patients experienced more delays in receiving endometrial cancer care than White patients.

Catherine Buerchner, MD, co-founder of Birch Concepts, LLC, discusses how the Soviflex vaginal retractor can help clinicians conduct vaginal repair.

In a recent study, women with a history of dysmenorrhea were at a significantly increased risk of endometriosis.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Lori Homa, MD, medical director at Allegheny Health Network, discusses how providers can best support their patients with PCOS.

In a recent study, women with premenstrual disorders were more likely to experience early menopause and vasomotor symptoms.

In a recent study, ovarian tissue cryopreservation was indicated as viable for preventing premature ovarian insufficiency in girls and young women receiving gonadotoxic therapies.

In a recent study, the 2013 WHO criteria for diagnosing gestational diabetes mellitus had a low sensitivity when used in individuals in low-risk early pregnancy.